Okami Medical Broadens Its Medical Devices Offerings
Okami Medical Expands Catheter Portfolio with SENDERO MAX
Okami Medical has made an exciting advancement in its embolization portfolio by obtaining 510(k) clearance for the SENDERO MAX Delivery Catheter from the U.S. Food and Drug Administration. This addition is significant as it enhances the existing SENDERO Microcatheter and LOBO occluders, allowing healthcare providers to have a more extensive array of tools for managing peripheral arterial blood flow obstruction across vessels ranging from 1.5mm to 9.0mm.
Innovative Features of the SENDERO MAX Catheter
The SENDERO catheters are specially designed for their optimal function alongside LOBO occluders. These catheters feature a hydrophilic coating, a stainless steel braid, and a radiopaque marker band. This unique design helps to improve trackability and ensures accurate device placement during procedures. Additionally, the tubes have a lubricious PTFE inner liner that facilitates smooth delivery of interventional devices, reducing friction and improving performance throughout the procedure.
Revolutionary Design Enhancements
With the LOBO occluders and the SENDERO catheters, Okami Medical utilizes a patented design coupled with proprietary HDBRAID® technology. This collaboration leads to a highly effective pore structure that significantly diminishes blood flow while promoting rapid vessel closure. By incorporating these advances, Okami Medical is raising the standards of care available to interventional radiologists.
Voices from the Medical Community
According to Rhonda Robb, President and CEO of Okami Medical, the introduction of the SENDERO catheter portfolio reflects their commitment to expanding treatment options for medical professionals. "We are excited to offer another delivery tool that enhances treatment with LOBO vascular occluders. The SENDERO MAX allows physicians to efficiently use various LOBO sizes, making patient management both swift and effective," she stated.
Dr. Nima Kokabi, a noted Interventional Radiologist, shared enthusiasm for the new catheter, indicating that its incorporation into medical practice provides an integrated solution for occlusion and delivery. He remarked, "With the SENDERO Microcatheter, I have effectively utilized LOBO-3 and LOBO-5, and now I am eager to leverage SENDERO MAX to work with LOBO-7 and LOBO-9. This expanded portfolio means we can confidently move beyond older technologies, allowing us to treat a broader range of cases rapidly and predictably."
Okami Medical: Pioneers in Medical Device Innovation
Founded in 2017, Okami Medical, Inc. is dedicated to creating innovative medical devices that are versatile and easy to use for managing peripheral vessel obstruction. As a company born from Inceptus Medical, an incubator for medical innovations, Okami is grounded in a solid foundation of expertise and industry success. They are also backed by a knowledgeable board of directors and strategic partners like Vensana Capital and U.S. Venture Partners. This impressive network enhances Okami’s capacity to deliver state-of-the-art solutions that improve patient care.
Looking Ahead for Okami Medical
As Okami Medical continues to grow and develop new technologies, the company remains focused on addressing the challenges faced by physicians in treating patients effectively. With the SENDERO MAX Delivery Catheter now available, practitioners can expect improved treatment capabilities that leverage the advances in medical device technology. The commitment of Okami Medical to drive innovation will likely play a significant role in shaping the future of peripheral vascular treatments.
Frequently Asked Questions
What is the SENDERO MAX Delivery Catheter?
The SENDERO MAX Delivery Catheter is an advanced medical device designed for embolization procedures, recently cleared by the FDA.
How does SENDERO MAX enhance treatment options?
It provides a versatile delivery solution that improves the effectiveness and efficiency of using LOBO vascular occluders in various peripheral vessel treatments.
Who is the target user of SENDERO products?
SENDO products, including SENDERO MAX, are primarily aimed at interventional radiologists and healthcare professionals involved in vascular treatments.
What technology does the SENDERO MAX utilize?
It employs advanced design features such as hydrophilic coating and proprietary HDBRAID® technology that enhances occlusion efficacy and device placement precision.
How long has Okami Medical been in operation?
Okami Medical was established in 2017 and has consistently focused on developing innovative solutions for peripheral vascular occlusion.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.